The Colposcopy and Treatment form has been updated and should be used for all colposcopies performed from 1 December 2018.
Order or download the form
Order pads of the Colposcopy & Treatment Forms at no cost to you.
Download the Colposcopy and Treatment Form (PDF 457 KB)
What is the purpose of colposcopy notification?The National Cervical Screening Program (NCSP) requires the notification of colposcopy episodes to the National Cancer Screening Register (the Register).
The information provided will inform participant clinical pathways and support the safety net function of the Register. Colposcopy notification will also enable quality and safety monitoring of the NCSP across the cervical screening pathway, and support high quality service delivery through monitoring of the colposcopy diagnostic and therapeutic standards and targets.
Why has the form been updated?The National Cancer Screening Register Rules 2017 have recently been amended, with changes to come into effect on 1 December 2018.
The Colposcopy and Treatment form has been updated to comply with the amended requirements of the National Cancer Screening Register Rules 2017, as well as to introduce improvements to the design and layout to better assist reporting of this important information for the NCSP.
Reporting of this demographic information will allow for the NCSP to support the ongoing quality and safety monitoring of cervical screening in Aboriginal and/or Torres Strait Islander and culturally and linguistically diverse populations, as well as to inform policy to improve services and education.
Will colposcopists receive reports about the colposcopies they perform?The information collected from the Colposcopy and Treatment forms submitted to the Register will inform the NCSR Colposcopy Quality Assurance Report (Report) for individual colposcopists.
To ensure the continued delivery of high quality colposcopy services, the Report will promote the maintenance and improvement of colposcopists’ clinical skills by supporting ongoing certification processes for individual colposcopists, and providing a national level comparison.
The reports will be based on aggregated data, not individual procedures.
We are currently incorporating feedback from our clinical experts and expect the initial report to be available for individuals in early 2019.
What is the legal basis for mandatory notification of cervical screening information?The National Cancer Screening Register Act 2016 (the Act) includes a requirement for prescribed individual healthcare providers to notify prescribed cervical screening information to the CMO by the prescribed timeframe. The details of the information to be notified to the Register are prescribed in the National Cancer Screening Register Rules 2017 (the Rules).
When do the Rules take effect?The requirement to notify prescribed information to the Commonwealth Chief Medical Officer commenced on 1 December 2017.
The new requirement to notify Aboriginal and/or Torres Strait Islander status, country of origin and preferred language, if known, is due to commence on 1 December 2018.
Find out more about the National Cancer Screening Rules 2017.
How will colposcopists notify the CMO?
Approved Form:The Colposcopy & Treatment Form will be used to notify colposcopy information to the CMO. This form contains the prescribed information and provides instructions on how to complete the form as well as definitions for terminology used in the form.
The Colposcopy & Treatment Form is an approved form for the purpose of section 25 of the Act.
More information can be found on our FAQ’s page